Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia
NCT01231841
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Aplastic Anemia
Interventions
DRUG:
cyclosporine
BIOLOGICAL:
anti-thymocyte globulin
Sponsor
The Cleveland Clinic